primary dysmenorrhea. primary dysmenorrhea
Conditions
Interventions
Intervention 1: Intervention 1: Taking Capsules containing 600 mg Calcium once a day from day 15 of menstural cycle to reliefing dysmenorrhea in the following cycle. Intervention 2: Intervention 2: Ta
Treatment - Drugs
Intervention 1: Taking Capsules containing 600 mg Calcium once a day from day 15 of menstural cycle to reliefing dysmenorrhea in the following cycle
Intervention 2: Taking Capsules containing 600 mg Calcium and 300 mg magnesium once a day from day 15 of menstural cycle to reliefing dysmenorrhea in the following cycle
Control group: Taking Placebo Capsules once a day from day 15 of menstural cycle to reliefing dysmenorrhea in the following cycle
Sponsors
Tabriz University of Medical Sciences, Aras branch
Eligibility
Sex/Gender
Female
Age
18 Years to 34 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Single students aged 18-34 years residing in Aras dormitory, having primary dysmenorrhea, regular and painful menstruation in previous 1 year with pain score equal or more than 5 according to visual analogue scale (medium to severe dysmenorrhea); consent to participate the study Exclusion criteria: Known serious diseases like epilepsy, severe digestive disorders, cardiovascular or renal diseases, pelvic inflammatory diseases; consumption of oral contraceptive pills in previous 6 months or desire to take them during study; allergy to NSAIDs.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean severity of menstrual pain. Timepoint: for 2 months after intervention, 1 day before starting mensturation tol 3 days after it, measured once every 6 hours. Method of measurement: Visual Analogue Scale.;Resting length due to dysmenorhea. Timepoint: for 2 months after intervention. Method of measurement: daily recording of resting length by the participants on a form. | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom Severity during Mensturation. Timepoint: during 2 months after intervention. Method of measurement: Symptom Severity Scale.;Need to take additional pain relief drug for dysmenorrhea. Timepoint: for two months after starting intervention. Method of measurement: No of Mephenamic Capules used.;Volume of menstural bleeding. Timepoint: for two months after starting intervention. Method of measurement: Higham table. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSalime Nezamivand-Chegini
Tabriz University of Medical Sciences, Aras Unit
Outcome results
None listed